Number of Employees: Approximately 1,800
Marlboro, Delicados, Benson & Hedges, Faros
Welcome to Philip Morris México, the leader in the Mexican tobacco market. More than seven out of every ten cigarettes sold in México is a Philip Morris brand. Its subsidiary, Philip Morris Cigatam Productos y Servicios, S. de R.L. de C.V., employs around 1,900 people and our portfolio includes Marlboro – the leading brand in the market – and Delicados, one of México’s oldest brands. Philip Morris Mexico operates one factory in Guadalajara and one Stemmery plant in Tepic, which manufactures tobacco products for the Mexican market and for other markets in the Latin American region.
Philip Morris México is an active contributor to organizations that address social problems such as hunger, child labor, and environmental degradation in México.
Based on PMI guidelines, recently the National Institute of Women granted Philip Morris Mexico (PMM) the “Gender Equity Model” certification. Through this certificate, PMM practices was recognized for its high standards of contributions, equity, diversity and inclusion, and for promoting a culture of work life balance.
Smoking and Health
Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.
All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.
To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes.
While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products.